[go: up one dir, main page]

FI114097B - Trisyklisiä 5,6-dihydro-9H-pyratsolo[3,4-c]-1,2,4-triatsolo[4,3-alfa]pyridiinejä - Google Patents

Trisyklisiä 5,6-dihydro-9H-pyratsolo[3,4-c]-1,2,4-triatsolo[4,3-alfa]pyridiinejä Download PDF

Info

Publication number
FI114097B
FI114097B FI974434A FI974434A FI114097B FI 114097 B FI114097 B FI 114097B FI 974434 A FI974434 A FI 974434A FI 974434 A FI974434 A FI 974434A FI 114097 B FI114097 B FI 114097B
Authority
FI
Finland
Prior art keywords
pyrazolo
triazolo
pyridine
ethyl
cyclopentyl
Prior art date
Application number
FI974434A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI974434A0 (fi
FI974434L (fi
Inventor
Kelvin Cooper
Allen Jacob Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI974434A0 publication Critical patent/FI974434A0/fi
Publication of FI974434L publication Critical patent/FI974434L/fi
Application granted granted Critical
Publication of FI114097B publication Critical patent/FI114097B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI974434A 1995-06-06 1997-12-05 Trisyklisiä 5,6-dihydro-9H-pyratsolo[3,4-c]-1,2,4-triatsolo[4,3-alfa]pyridiinejä FI114097B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IB9500429 1995-06-06
PCT/IB1995/000429 WO1996039408A1 (en) 1995-06-06 1995-06-06 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
CA002223624A CA2223624C (en) 1995-06-06 1995-06-06 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
CA2223624 1995-06-06
HU9601541 1996-06-05
HU9601541A HUP9601541A3 (en) 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
FI974434A0 FI974434A0 (fi) 1997-12-05
FI974434L FI974434L (fi) 1997-12-05
FI114097B true FI114097B (fi) 2004-08-13

Family

ID=89994031

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974434A FI114097B (fi) 1995-06-06 1997-12-05 Trisyklisiä 5,6-dihydro-9H-pyratsolo[3,4-c]-1,2,4-triatsolo[4,3-alfa]pyridiinejä

Country Status (43)

Country Link
US (1) US6004974A (de)
EP (1) EP0837860B1 (de)
JP (1) JP3107827B2 (de)
KR (2) KR100191972B1 (de)
CN (1) CN1061044C (de)
AP (1) AP609A (de)
AR (1) AR002745A1 (de)
AT (1) ATE214700T1 (de)
AU (1) AU694871B2 (de)
BG (1) BG62568B1 (de)
BR (1) BR9602627A (de)
CA (1) CA2223624C (de)
CO (1) CO4700460A1 (de)
CZ (1) CZ287251B6 (de)
DE (1) DE69525978T2 (de)
DK (1) DK0837860T3 (de)
DZ (1) DZ2044A1 (de)
ES (1) ES2172583T3 (de)
FI (1) FI114097B (de)
HR (1) HRP960268B1 (de)
HU (1) HUP9601541A3 (de)
IL (1) IL118485A (de)
IS (1) IS1913B (de)
LV (1) LV11620B (de)
MA (1) MA23893A1 (de)
MX (1) MX9709897A (de)
MY (1) MY116527A (de)
NO (1) NO306256B1 (de)
NZ (1) NZ286734A (de)
OA (1) OA10458A (de)
PL (1) PL184195B1 (de)
PT (1) PT837860E (de)
RO (1) RO115881B1 (de)
RU (1) RU2161158C2 (de)
SA (1) SA96170065B1 (de)
SG (1) SG54341A1 (de)
SI (1) SI9600186A (de)
SK (1) SK282167B6 (de)
TN (1) TNSN96083A1 (de)
TR (1) TR199600482A1 (de)
TW (1) TW460469B (de)
WO (1) WO1996039408A1 (de)
YU (1) YU49346B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792938B1 (fr) 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
EP1380585B1 (de) * 1999-04-30 2004-11-10 Pfizer Products Inc. Pyrazolopyridinon als Zwischenprodukt
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
ATE320800T1 (de) 1999-08-21 2006-04-15 Altana Pharma Ag Synergistische kombination von roflumilast und salmeterol
CA2402384A1 (en) 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
DE60216588T2 (de) * 2001-05-25 2007-09-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
WO2002096463A1 (en) * 2001-05-25 2002-12-05 Pfizer Inc. A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
GB0122031D0 (en) * 2001-09-12 2001-10-31 Pfizer Ltd Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
US20050107420A1 (en) * 2002-05-23 2005-05-19 Boehringe Ingelheim Pharma Gmbh & Co. Kg Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
EP1624893A2 (de) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Phosphodiesterase inhibitoren in der unfruchtbarkeit
WO2006075748A1 (ja) * 2005-01-17 2006-07-20 Santen Pharmaceutical Co., Ltd. アレルギー性結膜疾患治療剤
JP2009512676A (ja) 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ムスカリン性受容体アンタゴニストの医薬組成物
SI2363130T1 (sl) 2006-07-05 2014-09-30 Takeda Gmbh Kombinacija inhibitorjev HMG-CoA reduktaze atorvastatina ali simvastatina z inhibitorjem fosfodiesteraze 4, kot je roflumilast, za zdravljenje vnetnih pljučnih bolezni
WO2010043676A1 (en) * 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor
WO2011067145A1 (en) 2009-12-04 2011-06-09 Nerviano Medical Sciences S.R.L. Tricyclopyrazole derivatives
WO2013084182A1 (en) 2011-12-08 2013-06-13 Glenmark Pharmaceuticals S.A. Pharmaceutical composition that includes a pde4 enzyme inhibitor and an analgesic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697532A (en) * 1970-08-12 1972-10-10 Squibb & Sons Inc 5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
EP0707585A1 (de) * 1993-07-06 1996-04-24 Pfizer Inc. Bicyclische tetrahydropyrazolopyridine
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives

Also Published As

Publication number Publication date
ATE214700T1 (de) 2002-04-15
DK0837860T3 (da) 2002-05-27
SK71896A3 (en) 1997-05-07
PL314459A1 (en) 1996-12-09
AR002745A1 (es) 1998-04-29
CN1142499A (zh) 1997-02-12
KR970003440A (ko) 1997-01-28
ES2172583T3 (es) 2002-10-01
HU9601541D0 (en) 1996-07-29
AP9600806A0 (en) 1996-07-31
YU34696A (sh) 1999-07-28
TR199600482A1 (tr) 1997-03-21
AP609A (en) 1997-09-03
EP0837860B1 (de) 2002-03-20
IS4350A (is) 1996-12-07
DE69525978D1 (de) 2002-04-25
PL184195B1 (pl) 2002-09-30
JP3107827B2 (ja) 2000-11-13
NZ286734A (en) 1998-02-26
NO962320L (no) 1996-12-09
TNSN96083A1 (fr) 2005-03-15
BG100640A (bg) 1997-03-31
CA2223624C (en) 2001-02-20
MA23893A1 (fr) 1996-12-31
NO306256B1 (no) 1999-10-11
FI974434A0 (fi) 1997-12-05
BG62568B1 (bg) 2000-02-29
BR9602627A (pt) 1998-09-01
JPH10510242A (ja) 1998-10-06
LV11620B (en) 1997-04-20
HUP9601541A2 (en) 1997-02-28
RU2161158C2 (ru) 2000-12-27
AU5477396A (en) 1996-12-19
US6004974A (en) 1999-12-21
CO4700460A1 (es) 1998-12-29
RO115881B1 (ro) 2000-07-28
IL118485A0 (en) 1996-09-12
HRP960268B1 (en) 2002-12-31
KR100225719B1 (en) 1999-10-15
SK282167B6 (sk) 2001-11-06
CZ287251B6 (en) 2000-10-11
IL118485A (en) 2000-02-17
TW460469B (en) 2001-10-21
CN1061044C (zh) 2001-01-24
OA10458A (en) 2002-03-27
DZ2044A1 (fr) 2002-07-21
NO962320D0 (no) 1996-06-05
EP0837860A1 (de) 1998-04-29
MY116527A (en) 2004-02-28
FI974434L (fi) 1997-12-05
LV11620A (lv) 1996-12-20
CA2223624A1 (en) 1996-12-12
WO1996039408A1 (en) 1996-12-12
HUP9601541A3 (en) 1997-05-28
HRP960268A2 (en) 1997-08-31
PT837860E (pt) 2002-07-31
SA96170065B1 (ar) 2005-12-21
CZ162696A3 (en) 1997-01-15
KR100191972B1 (ko) 1999-06-15
AU694871B2 (en) 1998-07-30
IS1913B (is) 2004-02-03
SI9600186A (en) 1997-04-30
YU49346B (sh) 2005-07-19
DE69525978T2 (de) 2002-12-19
SG54341A1 (en) 1998-11-16
MX9709897A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
FI114097B (fi) Trisyklisiä 5,6-dihydro-9H-pyratsolo[3,4-c]-1,2,4-triatsolo[4,3-alfa]pyridiinejä
US8138193B2 (en) Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
US6303613B1 (en) Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals
AU2007275816A1 (en) 1-hydroxy naphthyridine compounds as anti-HIV agents
TW201136936A (en) Pyrrolopyrazine kinase inhibitors
KR20100114095A (ko) 피롤로피라진 키나아제 저해제
US20090036482A1 (en) Imidazopyridine-derivatives as inductible no-synthase inhibitors
CA2540230A1 (en) Aminopyridine-derivatives as inductible no-synthase inhibitors
AP932A (en) Tricyclic 5,6-dihydro-9H-pyrazolo (3,4c)-1,2,4,-triazolo (4,3-a) pyridines.
AU7091198A (en) Compounds
WO2000006576A1 (en) Compounds
UA45961C2 (uk) ТРИЦИКЛІЧНІ 5,6-ДИГІДРО-9Н-ПІРАЗОЛО[3,4-с]-1,2,4-ТРИАЗОЛО[4,3-а]ПІРИДИНИ, СПОСІБ ІНГІБУВАННЯ ФОСФОДІЕСТЕРАЗИ (PDE) ТИПУ IV, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ
MXPA99009188A (en) Compounds